investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Oncogenic Signaling by DF3/MUC1 in Human Breast Cancer
Donald W. Kufe
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Donald W. Kufe
Dana-Farber Cancer Institute
Boston, United States
Related projects
Joseph Barchi
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines
Breast
Claudia Palena
Novel Targets for Vaccine Therapy
Breast
Shiv Grewal
Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome
Breast
Thomas Ried
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
Breast
Joyce M Slingerland
Effects of the PI3K Pathway on p27 Function and Cancer Progression
Breast
Michael J Holliday
Mapping and Controlling the Segmental Dynamic Networks of Cyclophilin A as they Relate to Enzymatic Function
Breast
Larry Norton
Program Project in Models of Breast Cancer
Breast
Pathology
Thangaiyan Rabi
Novel Oleanane Triterpenoid AMR-MeOAc for Breast Cancer Prevention and Therapy
Breast
Richard M Weinshilboum
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Breast